Developing vaccines to protect against Ebola and related viruses
Advanced Development of Vaccines for Filoviruses
This study is working on a new vaccine that could help protect people from several serious viruses like Ebola, Marburg, and Lassa Fever, and it’s designed to be easy to store and use, making it safer and more accessible for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Auro Vaccines LLC NIH-funded |
| Lab location | 1 site (East Windsor, United States) |
| Project ID | NIH-10382998 on NIH RePORTER |
What this research studies
This research focuses on creating a multivalent vaccine that can protect against several dangerous viruses, including Ebola, Marburg, and Lassa Fever. The approach involves formulating a stable vaccine that can be lyophilized, which means it can be dried and stored for easier distribution and use. The research will also support the manufacturing process under strict guidelines to ensure safety and effectiveness, and it aims to prepare the necessary documentation for clinical trials to evaluate the vaccine's performance in humans.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals at high risk of exposure to Ebola, Marburg, or Lassa Fever, such as healthcare workers or those living in endemic regions.
Not a fit: Patients who are not at risk of exposure to these viruses or who have already been vaccinated against them may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new vaccine that protects against multiple deadly viruses, potentially saving many lives.
How similar studies have performed: Other research has shown promise in developing vaccines for similar viral infections, indicating that this approach could be effective.
Where this research is happening
East Windsor, United States
- Auro Vaccines LLC — East Windsor, United States (Active)
Researchers
- Principal investigator: Eldridge, John — Auro Vaccines LLC
- Study coordinator: Eldridge, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.